Commentary|Podcasts|August 22, 2023

Where Digital Health Technology Intersects with Pharma

Author(s)Lisa Henderson
Andy Studna, Senior Editor

Innovative pharma companies are stepping up to integrate digital health technology to advance pharmaceutical drug and medical device development, in both the healthcare and research worlds, to achieve better measurements and outcomes.

Chris Economos, Vice President and Head of Life Sciences at Eko, discusses his career journey from pharma to digital health technology, where he recognized the power of AI and digital health to improve clinical care and research. He discusses the current ability of AI in the future use of digital measurements and biomarkers to improve clinical trials, as well as outcomes.

About the speaker

Chris Economos, as Vice President and Head of Life Sciences for Eko, cultivates strategic and commercial relationships with medical technology and pharmaceutical companies. Economos was previously SVP of Corporate Development for physIQ Inc, as well as roles with Healthy Interactions, Abbvie, ZymoGenetics, and Deloitte. He holds a Bachelor of Science degree from Vanderbilt University and an MBA from the Indiana University Kelley School of Business.

About the ACT Podcast

The editors of Applied Clinical Trials bring you the latest commercial insights to master the science of success. Podcast episodes examine current trends, key conferences, and critical topics in the bio/pharmaceutical industry.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!